Across TCGA pan-cancer cohorts, GAS2L1P2 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated GAS2L1P2 data layer compared with 1 for mutation status.
The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher GAS2L1P2 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated GAS2L1P2 expression acts as an unfavorable survival marker, although some lineages such as CESC and SKCM show a favorable association.
CESC, SKCM, and UVM are the cancer types where GAS2L1P2 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.